Final Rule on Cannabis Rescheduling Could Publish in Fall 2024, Sklamberg Says

7 months ago

June 21, 2024 Life Sciences & Healthcare Regulatory partner Howard Sklamberg was recently featured in the MarketWatch article, “These cannabis stocks have solid growth prospects — with help from the Biden administration.” The article discusses the U.S. Department of Health and Human Services’ (HHS) recommendation to move cannabis from Schedule I to Schedule III, which was issued […]